Post-IPO Equity Therapeutics Companies

Pasithea Therapeutics is a biotechnology company that seeks to solve clinical problems such as mental health.

Replimune Group develop the next generation of ‘oncolytic immunotherapies’ for the treatment of cancer.

BioTE is a medical company that provides bioidentical hormone pellet therapy.

Kairos Pharma is a clinical-stage biopharmaceutical company focused on cancer immunotherapy and drug resistance.

Dogwood Therapeutics is a clinical-stage biopharmaceutical company developing novel antiviral therapies for fibromyalgia and other diseases.

Invivyd develops antibodies to transcend the limitations of the human immune system and fight against viral infections.

MaaT Pharma (Microbiota as a Therapy) is a French biotech start-up.

Atlantic Coastal Acquisition Corp. II is a blank check company.

Adicet Bio is a biotechnology company discovering and developing first-in-class allogeneic gamma delta CAR t cell therapies for cancer

Biomea Fusion is a precision oncology company developing novel small molecules that target aggressive forms of cancer.

Isla Pharmaceuticals is a biotechnology company that develops tropical disease therapies.

Kezar Life Sciences company focused on the discovery and development of drugs targeting protein homeostasis for autoimmune disorders

Intensity Therapeutics is a biopharmaceutical company that provides chemotherapy treatment for cancer patients.

Arcus Biosciences is a biopharmaceutical company that discovers, develops, and commercializes novel therapies for the treatment of cancer.

Kiromic develops biomarker- and small molecule-based diagnostic and therapeutic programs for solid tumors and hematologic malignancies.

Repare Therapeutics is a developer of oncology drugs designed to target specific vulnerabilities of tumor cells.

X4 Pharmaceuticals is a clinical-stage oncology company developing oral small molecule CXCR4 antagonists for the treatment.

Harpoon Therapeutics is a clinical-stage immunotherapy company focused on the development of novel T-cell recruiting biologic therapies.

Nurix Therapeutics is a biopharmaceutical company that focuses on the development and discovery of small molecule drugs.

Disc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood disorders.

Rapt is focused on the discovery and development of novel small-molecule agents to activate the immune system to eradicate cancer.

Rani is a clinical-stage biotherapeutics company that enables the development of orally administered biologics to improve patient outcomes.

LEXEO Therapeutics utilizes gene therapy to treat genetically defined cardiovascular and central nervous system diseases.

C4 Therapeutics develops novel early stage therapies that eliminate disease-causing proteins.

AtaiBeckley develops innovative mental health treatments that address significant unmet medical needs.